+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Germany Diabetes Market, by Continuous Glucose Monitoring (CGM), Blood Glucose (SMBG) Device, Insulin Pen, Insulin Pump, Reimbursement Company Analysis & Forecast

  • ID: 5134052
  • Report
  • July 2020
  • Region: Germany
  • 146 pages
  • Renub Research

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • DEXCOM INC
  • Insulet Corporation
  • Medtronic
  • Owen Mumford Ltd
  • MORE
Diabetes mellitus is a significant public health problem and one of the biggest challenges for healthcare systems all over Germany. The prevalence of known type 1 & 2 diabetes in the German adult population is very high; also, it is considered that a high number of patients are not yet diagnosed with the disease. Due to an ageing population and unhealthy lifestyle, the prevalence of type 2 diabetes is expected to increase steadily over the next few years. High-quality care, including adequate monitoring, control of risk factors and active self-management are the key factors for preventing costly and burdensome micro- and macrovascular complications in German patients with type 2 diabetes. According to this report, Germany Diabetes Market is expected to be USD 12 Billion by the end of the year 2025.

In this report, Germany Diabetic market is segmented into four parts; Insulin Pen, CGM, SMBG, and Insulin Pump. All the four insulin delivery devices segment mentioned above are growing year on year. With the rising incidences of diabetic problems, various digital care solutions have been introduced in the country to help people with diabetes. Robert Koch Institute (RKI), The German federal disease control and prevention research institute has been developing a public health surveillance system. It focuses on long-term data, collection of comparable and ensuring the establishment of efficient surveillance structures for monitoring relevant indicators of diabetes.

In 2019, a country-wide campaign, called ‘Sche1sstyp’, was initiated by the Germany-based research centre, Helmholtz Zentrum München. The campaign addresses the prevention and early detection of type 1 diabetes. In June 2019, the 2nd World Conference on Diabetes and Endocrinology was organized in Berlin, which included various research presentations provided by global leaders in diabetes and endocrinology. The Coronavirus (COVID-19) disease has affected the Germany Diabetes market. For people living with diabetes, it is essential to take precautions to avoid the virus if possible.

This report titled “Germany Diabetes Market, By Self Monitoring Blood Glucose Device (SMBG Market by, Test Strips, Lancet, Meter, Blood Glucose Device Users & Reimbursement) Continuous Glucose Monitoring (CGM Market by Components, Glucose Sensor, Transmitter, CGM User, Reimbursement), Insulin Pen (Disposable, Reusable & Smart Insulin Pen, Needle Market, Reimbursement Policies), Insulin Pump Market, (Differentiation Points of Insulin Pump Products, Training Model for Patients & HCP) Companies (Insulet Corporation, B. Braun Melsungen AG, LifeScan Inc., Artsana S.p.A, BD, Novo Nordisk A/S, Owen Mumford Ltd, Ypsomed AG, Medtronic, Eli Lilly and Company, Abbott Laboratories)” provides a complete analysis of Germany Insulin Devices Market.

Segmentation based on device

1. CGM
2. SMBG
3. Insulin Pen
4. Insulin Pump

United States Diabetic Market- Device Segment Analysis

1. CGM

a) Glucose Sensor Market & Forecast
b) CGM Transmitter Market & Forecast
c) CGM User
d) CGM Reimbursement

2. SMBG

a) Test Strips Market and Forecast
b) Lancet Market and Forecast
c) Meter Market and Forecast
d) Blood Glucose (SMBG) Users
e) Blood Glucose Devices Reimbursement

3. Insulin Pen Market

a) Disposable Insulin Pen
b) Reusable Insulin Pen
c) Smart Insulin Pen
d) Insulin Pen Needle Market
e) Reimbursement Policies

4. Insulin Pump Market

a) Insulin Pump Market
b) Insulin Pump Users
c) Reimbursement Policies

Company Analysis

1. B. Braun Melsungen AG
2. Eli Lilly and Company
3. Artsana S.p.A
4. BD
5. Novo Nordisk A/S
6. Owen Mumford Ltd
7. Ypsomed AG
8. Medtronic
9. Insulet Corporation
10. LifeScan Inc.
11. Abbott Laboratories
12. DEXCOM INC
13. Roche

All the Companies Studied in the Report have been Studied from 3 Points
  • Company Overview
  • Recent Developments
  • Financial Insight
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • DEXCOM INC
  • Insulet Corporation
  • Medtronic
  • Owen Mumford Ltd
  • MORE
1 Introduction

2 Research & Methodology

3 Executive Summary

4 Market Dynamic
4.1 Growth Driver
4.1.1 Rising Diabetes Mellitus in an Aging Population
4.1.2 Rising prevalence of diabetes in various age groups
4.1.3 Rising Government Funding for Diabetes Management
4.1.4 Benefits of Insulin Pump over Multiple Daily Injection
4.1.5 Lifestyle-Compatible Treatment Options and Technological Advancement in Insulin Pump Devices
4.2 Challenges
4.2.1 Technological Advancements in Insulin Infusion Devices
4.2.2 Blood Glucose Meter Accuracy Problem Acknowledged by FDA, Industry & Clinicians
4.2.3 Low Compliance of Glucose Monitoring & Inadequate Reimbursement for SMBG Supplies
4.2.4 Safety Issues in Insulin Pump Devices
4.2.5 Difficulties Associated with the Pump
4.2.5.1 Weight Gain
4.2.5.2 Diabetic Ketoacidosis
4.2.5.3 Infection and Infusion Site Reactions
4.2.6 Adherence

5 Analysis - Germany Diabetic
5.1 Market

6 Population
6.1 Diabetes Population
6.1.1 Type 1
6.1.2 Type 2

7 Market Share Analysis - Germany Diabetic
7.1 By Types

8 CGM Market
8.1 Germany - CGM Market by Components
8.1.1 Glucose Sensor Market & Forecast
8.1.2 CGM Transmitter Market & Forecast
8.2 Germany - CGM User (2011 - 2025)
8.3 CGM Reimbursement in Germany

9 Blood Glucose Device (SMBG)
9.1 Market
9.1.1 Type 1 & Type 2 (Diabetes)
9.2 Test Strips Market and Forecast
9.2.1 Type 1 & Type 2 (Diabetes)
9.3 Lancet Market and Forecast
9.3.1 Type 1 & Type 2 (Diabetes)
9.4 Meter Market and Forecast
9.4.1 Type 1 & Type 2 (Diabetes)
9.5 Blood Glucose (SMBG) Users and Forecast
9.5.1 Type 1 & Type 2 (Diabetes)
9.6 Reimbursement of Blood Glucose Devices in Germany

10 Insulin Pen Market
10.1 Insulin Pen User
10.2 Types - Insulin Pen Market & Users
10.2.1 Disposable Insulin Pen
10.2.1.1 Market
10.2.1.2 User
10.2.2 Reusable Insulin Pen
10.2.2.1 Market
10.2.2.2 User
10.2.3 Smart Insulin Pen
10.2.3.1 Market
10.2.3.2 User
10.3 Insulin Pen Needle Market
10.4 Reimbursement Policies

11 Insulin Pump Market
11.1 Insulin Pump Market
11.1.1 Type 1 & Type 2 (Insulin Pump Market & Forecast)
11.2 Insulin Pump Users
11.2.1 Type 1 & Type 2 (Insulin Pump User & Forecast)
11.3 Reimbursement Policies on Insulin Pump

12 Company Analysis
12.1 Key Players in Insulin Pen
12.1.1 B. Braun Melsungen AG
12.1.1.1 Overview
12.1.1.2 Initiatives & Recent Developments
12.1.1.3 Revenue
12.1.2 Eli Lilly and Company
12.1.2.1 Overview
12.1.2.2 Initiatives & Recent Developments
12.1.2.3 Revenue
12.1.3 Artsana S.p.A.,
12.1.3.1 Overview
12.1.3.2 Initiatives & Recent Developments
12.1.3.3 Revenue
12.1.4 BD
12.1.4.1 Overview
12.1.4.2 Initiatives & Recent Developments
12.1.4.3 Revenue
12.1.5 Novo Nordisk A/S
12.1.5.1 Overview
12.1.5.2 Initiatives & Recent Developments
12.1.5.3 Revenue
12.1.6 Owen Mumford Ltd.
12.1.6.1 Overview
12.1.6.2 Initiatives & Recent Developments
12.1.6.3 Revenue
12.1.7 Ypsomed AG
12.1.7.1 Overview
12.1.7.2 Initiatives & Recent Developments
12.1.7.3 Revenue
12.2 Key Players in Insulin Pump
12.2.1 Medtronic
12.2.1.1 Overview
12.2.1.2 Insulin Pump - Product Details
12.2.1.3 Revenue
12.2.1.4 Insulin Pump - Latest Development & Trends
12.2.2 Insulet Corporation
12.2.2.1 Overview
12.2.2.2 Insulin Pump - Product Details
12.2.2.3 Revenue
12.3 Key Players in SMBG
12.3.1 LifeScan Inc.
12.3.1.1 Overview
12.3.1.2 LifeScan SMBG Revenue& Forecast
12.3.2 Abbott Laboratories
12.3.2.1 Overview
12.3.2.2 Recent Development
12.3.2.3 Abbott Laboratories SMBG Revenue& Forecast
12.4 Key Players in CGM
12.4.1 Dexcom Inc
12.4.1.1 Overview
12.4.1.2 Recent Development
12.4.1.3 Revenue& Forecast
12.4.2 Abbott Laboratories
12.4.2.1 Overview
12.4.2.2 Recent Development
12.4.3 Roche
12.4.3.1 Overview
12.4.3.2 Recent Development
Note: Product cover images may vary from those shown
  • B. Braun Melsungen AG
  • Eli Lilly and Company
  • Artsana S.p.A
  • BD
  • Novo Nordisk A/S
  • Owen Mumford Ltd
  • Ypsomed AG
  • Medtronic
  • Insulet Corporation
  • LifeScan Inc.
  • Abbott Laboratories
  • DEXCOM INC
  • Roche
Note: Product cover images may vary from those shown

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...

Adroll
adroll